Coronado Biosciences
Company Profile
Industry:Biotechnology
Site:coronadobiosciences.com
Description:Coronado is a biopharmaceutical company focused on novel immunotherapy agents for cancer and inflammatory diseases. Coronado’s two principal pharmaceutical product candidates are initially targeted for clinical development for inflammatory bowel disease, multiple sclerosis and acute myeloid leukemia.
In November 2007, Coronado acquired from UCL Business PLC, an affiliate of University College London ("UCLB"), exclusive worldwide rights to develop and market CNDO-109, a compound that...
Specialties:ONCOLOGY THERAPEUTICS MARKET, MULTIPLE SCLEROSIS, AML, INFLAMMATORY BOWEL DISEASE, HYGIENE HYPOTHESIS
Founded:2006
Company size:11-50 employees
Who has worked at Coronado Biosciences
| Position at Coronado Biosciences | Previous job position | |
|---|---|---|
| Bob Criscola | Sr. Director of Clinical Data ManagementSince Oct 2012 |
|
| David Barrett | DirectorSince May 2011 |
Ventrus BiosciencesChief Financial Officer Since Jun 2010 |
| Karin Hehenberger | Executive Vice President, Chief Medical OfficerSince Dec 2011 |
Juvenile Diabetes Research FoundationSenior Vice President, Strategic alliances Jan 2010 - Sep 2011 |
| Kirian Szwed | Executive AssistantSince Mar 2012 |
McKinsey & CompanyExecutive Assistant Oct 2010 - Feb 2012 |
| Linda Rogers | VP Clinical Operations VP Clin Ops |
|
| Michael Ryan | Sr. Director of Clinical Research and OperationsSince Feb 2012 |
Endo PharmaceuticalsAssociate Director, Clinical Project Management Jan 2010 - Jan 2012 |
| Peggy Wentworth | VP Development Operations VP Development Operations2006 - 2011 |
Coronado BiosciencesVP Development Operations 2006 - 2011 |
| Susan Jandoli | Executive Assistant to the Chairman and CEOSince Jan 2013 |
And-One Consulting, LLCExecutive Assistant to Harlan F. Weisman, M.D. 2012 - 2013 |
Former Employees
| Position at Coronado Biosciences | Next job position | |
|---|---|---|
| Bryan Prentice | ConsultantSince Jun 2011 |
bluebird bioConsultant Since Oct 2012 |
| Cynthia Devall | Finance2011 - 2013 |
Devett GroupPartner Since 2011 |
| Gary Gemignani | Executive Vice President - Chief Operating Officer and Chief Financial OfficerMay 2010 - Jun 2011 |
Champions Oncology, Inc.Executive Vice President - CFO Since Nov 2012 |
| Gregory Lerch | Sr. VP, Regulatory Affairs & Pharm. SciencesMay 2011 - May 2013 |
Gregory LerchIndependent Consultant Since Jun 2013 |
| Kirsten Abell | EAJun 2010 - Sep 2010 |
UTC OTIS DivisionExecutive Assistant Since Jan 2012 |
| Richard Martin | Senior Consultant/QualityJun 2010 - Nov 2010 |